Recall
FDAHealthJuly 25, 2025

Alembic Pharmaceuticals Limited — Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panela v 389350, Gujarat, India, Manufactured for

⚠️ CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
July 25, 2025

Nationwide in the USA.

What's affected?

Product
Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panela v 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-637-31
UPC
0362332645312
Lot code
2305015142

Additional details

Lot: 2305015142, Exp. Date: 9/30/2025

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 9,492 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.